Thanks to the generous support of our community, the McGill University Health Centre (MUHC) Foundation has surpassed its goal, raising $5 million for the Dr. Miguel Burnier 20/20 Campaign in support of the Ocular Pathology Laboratory at the MUHC.
Half a million Canadians are estimated to be living with a form of vision loss, and with the aging population the prevalence of vision loss is expected to increase nearly 30 per cent in the next decade.
Dr. Miguel Burnier, the Director of the Ocular Pathology Laboratory, has made it his life’s work to combat eye diseases by conducting cutting-edge research.
Proceeds from the MUHC Foundation’s recent gala Le Bal Rouge held to celebrate Dr. Burnier’s achievements contributed $750,000 to the funds raised.
“We do not do research as an intellectual exercise, we do it because at the end of the day there is a patient who needs help,” he explains.
Under Dr. Burnier’s leadership and guidance, students from Canada and around the world train year-round at this exceptional state of the art facility located in the Research Institute of the MUHC.
“The Laboratory is an international leader in research, education and consultation,” notes Dr. Pierre Gfeller, President and Executive Director of the MUHC. “The lab’s expertise is enhanced by some of the most innovative research equipment and technology available.”
Dr. Burnier develops personalized treatments for patients living with eye disease here in Montreal, and around the world.
“Each and every day, Dr. Burnier and his team work to remain at the forefront of ocular diseases,” says MUHC Foundation President Julie Quenneville. “His leadership has helped to establish the MUHC as an international hub for eye disease research and care.”
A Full Professor of Ophthalmology, Pathology, Medicine and Oncology at McGill University, Dr. Burnier is the first Canadian to be chosen as the President of the Pan-American Association
of Ophthalmology. He is the recipient of a host of prestigious awards for excellence in his field, including The European Ophthalmology Award, and the World Health Organization Award for Melanoma research.
“We are so fortunate to have world-class physicians like Dr. Burnier at our hospital,” says MUHC Foundation Board Chair Norman Steinberg. “His dedication and commitment to his patients, and to ocular medicine, is truly inspiring.”